PHASE I TRIAL OF DNX-2401 ONCOLYTIC ADENOVIRUS COMBINED WITH A SHORT COURSE OF DOSE-DENSE TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA

Authors
Category Primary study
JournalNEURO-ONCOLOGY
Year 2023
This article has no abstract
Epistemonikos ID: 45a380d7fbdc350b9d69600e25d583379523b8da
First added on: Feb 16, 2025